Innovative R&D Focus ERBC specializes in bridging preclinical and clinical research through innovative in vitro and in vivo models, providing opportunities for biotech and pharma companies seeking cutting-edge translational solutions to accelerate their drug development pipelines.

Regulatory Expertise With comprehensive pre-IND packages and consultancy services, ERBC is well-positioned to assist organizations needing expert regulatory support, offering potential for partnerships aimed at streamlining clinical approvals and compliance processes.

Sustainability Commitment The company's emphasis on alternatives to animal testing aligns with growing industry trends towards ethical and sustainable research practices, creating avenues to collaborate with organizations prioritizing humane and eco-friendly methodologies.

Active Industry Engagement ERBC's active participation in major industry conferences such as FELASA, EUROTOX, and ACT indicates a strong presence in the toxicology and research community, providing opportunities to connect with key decision-makers and expand business relationships.

Growth Potential With revenue between 1 and 10 million dollars and a dedicated team of up to 500 employees, ERBC shows promising growth prospects within the biotech CRO space, offering potential clients access to experienced professionals and expanding capabilities.